C

Cycle Pharmaceuticals

Repurposes drugs for rare diseases

Medical Writer

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeCambridge, UK

About the Job

Requirements

  • A degree in life sciences or a related discipline is required.
  • Extensive experience in clinical and regulatory medical writing within the pharmaceutical, biotechnology or contract research organization industry, including lead authorship of Phase 3 protocols and clinical study reports.
  • Strong working knowledge of International Council for Harmonisation guidelines, including E3, E6, E9 and M4, Food and Drug Administration expectations, and electronic Common Technical Document structure.
  • Ability to interpret and present clinical and statistical data accurately.
  • Experience managing outsourced writing providers or freelance writers.
  • Excellent attention to detail, project management and stakeholder management skills, with the ability to influence across disciplines without direct authority.

Responsibilities

  • Lead the authoring of pivotal Phase 3 clinical documents, including protocols, amendments, informed consent forms, Investigator’s Brochure updates and final clinical study reports.
  • Own the preparation of clinical content for Food and Drug Administration meetings and marketing applications, including briefing packages, responses to regulatory questions, Common Technical Document Module 2.5 and 2.7 summaries, and integrated summaries of efficacy and safety.
  • Collaborate with Clinical Operations and contract research organizations to ensure data support is clear, accurate and consistent.
  • Lead the authoring of protocols and reports for Phase 4 and post-approval studies, including post-marketing requirement and commitment studies, open-label extensions, registries and observational studies.
  • Prepare clinical content for post-approval submissions, labelling supplements, annual reports and post-marketing study reports, and support Pharmacovigilance with periodic safety reports where required.
  • Prepare data monitoring and steering committee materials, patient-facing study information and plain language summaries, and contribute to manuscripts and congress materials in collaboration with relevant teams.
  • Lead clinical trial registration and results disclosure on ClinicalTrials.gov, ensuring consistency of data and key messages across protocols, reports, submissions and publications, while maintaining appropriate separation from promotional activities.
  • Collaborate with Regulatory to establish and maintain writing standards, templates, style guides and quality control processes aligned with relevant regulatory guidance, including ICH E3 and M11, ensuring documents are accurate, inspection-ready and appropriately archived.
  • Oversee document planning, timelines, review cycles and comment resolution, while forecasting medical writing resource needs and selecting and managing external writing providers.
  • Contribute to departmental budgeting, operational planning and prioritisation; maintain awareness of evolving regulatory and industry guidance; drive process improvements; and support the development of future direct reports and contract writers.

Desired Qualifications

  • Experience authoring clinical documents for a New Drug Application, Biologics License Application or Marketing Authorisation Application, including Common Technical Document Module 2 clinical summaries and integrated summaries.
  • Experience writing protocols and reports for post-approval studies, such as post-marketing requirement studies, open-label extensions, registries or observational studies.
  • Experience with clinical trial disclosure requirements, including ClinicalTrials.gov results posting.
  • Membership or certification with the European Medical Writers Association or American Medical Writers Association.
  • Experience with document management systems such as Veeva Vault.
  • A PhD or other advanced degree.

About the Company

Cycle Pharmaceuticals

Repurposes drugs for rare diseases

Cycle Pharmaceuticals develops and sells medicines that improve existing drugs for rare genetic diseases. It focuses on repurposing, reformulating, and reintroducing generic medications to treat rare metabolic, immunological, and neurological conditions (such as HT-1, PKU, MS). Its products are delivered as ready-to-use therapies in the United States, aided by the Cycle Vita patient support program that helps with education, insurance coordination, and affordability to ensure patients can stay on treatment. Unlike some peers that chase new molecular entities, Cycle builds value by optimizing existing drugs to fit patient needs, aiming for reliable cash flow, profitability, and the ability to fund acquisitions and growth. The company also operates a social mission to provide free medicines in developing countries. Overall, its goal is to improve quality of life for people with rare diseases while expanding access and maintaining sustainable operations.

Company size
201-500
Company stage
Debt Financing
Total funding
$25M
Headquarters
Cambridge, United Kingdom
Founded
2012

Recently Posted Jobs

Explore more opportunities at Cycle Pharmaceuticals

See more jobs